26Indexed trials
mesh condition
Brain Neoplasms
Intelligence
Brain Neoplasms intelligence: 26 indexed trials, 4 recruiting studies, 23 sponsors across 20 countries.
4Recruiting
23Sponsors
20Countries
Leading sponsors
NeuroVita Clinic20 recruiting
Duke University20 recruiting
Annick Desjardins20 recruiting
Costas Hadjipanayis11 recruiting
DelMar Pharmaceuticals, Inc.10 recruiting
Eli Lilly and Company10 recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS10 recruiting
INSYS Therapeutics Inc10 recruiting
Katy Peters, MD, PhD10 recruiting
Medical University of Vienna10 recruiting
NYU Langone Health10 recruiting
National Cancer Institute (NCI)10 recruiting
Geographic activity
United States16trials
Germany3trials
China2trials
Austria2trials
Canada2trials
Hong Kong2trials
Israel2trials
Italy2trials
Netherlands2trials
Russia2trials
Hungary1trials
Serbia1trials
Leading interventions
Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes2trials
Dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes2trials
Best Standard of Care1trials
Carboplatin1trials
Clevidipine1trials
Cognitive Training1trials
Computerized working memory training program (intervention)1trials
Computerized working memory training program (control)1trials
Bevacizumab1trials
Aminolevulinic acid hydrochloride1trials
Dexamethasone1trials
AZD74511trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.